Insulin resistance may predict poor blood flow after heart attack stenting in diabetics
NCT ID NCT07706335
First seen Jul 15, 2026 · Last updated Jul 17, 2026 · Updated 2 times
Summary
This study investigates whether insulin resistance, measured by the TyG index, is linked to the no-reflow phenomenon—where blood flow fails to restore properly—after primary PCI (stenting) for heart attacks in people with type 2 diabetes. Researchers will also examine how insulin resistance relates to the complexity of coronary artery blockages and in-hospital complications. The goal is to identify predictors that could improve outcomes for diabetic patients undergoing emergency heart attack treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this research could identify insulin resistance as a key predictor of poor blood flow after heart attack treatment in diabetic patients, potentially guiding future therapies.
- What could go wrong
- This is an observational study with a small sample size (100 participants), so findings may not apply broadly. It does not test a new treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETIC PATIENT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could the speed of blood sugar drop harm the eyes? a study puts it to the test.
- Fig leaf tea may shield kidneys from diabetes damage — a trial puts it to the test
- Can a nasal spray of insulin shield the aging brain from Post-Surgery confusion?
- Smartphone app could improve blood sugar control in type 2 diabetes
- Personalizing kidney treatment: can biomarkers predict who benefits from finerenone?
- Diabetes drug class may change how the bladder behaves